SANOFI (SAN.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:SAN - FR0000120578 - Common Stock
SAN.PA Key Statistics, Chart & Performance
The current stock price of SAN.PA is 81.61 EUR. In the past month the price decreased by -5.36%. In the past year, price decreased by -12.51%.
SAN.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SNW.DE | SANOFI | 10.84 | 200.10B | ||
| 1SAN.MI | SANOFI | 10.75 | 198.47B | ||
| MRK.DE | MERCK KGAA | 14.13 | 52.41B | ||
| 1MRK.MI | MERCK KGAA | 13.94 | 51.72B | ||
| UCB.BR | UCB SA | 36.68 | 45.81B | ||
| UNC.DE | UCB SA | 37.51 | 46.84B | ||
| BAYN.DE | BAYER AG-REG | 6.73 | 35.31B | ||
| 1BAYN.MI | BAYER AG-REG | 6.65 | 34.87B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 24.71 | 10.18B | ||
| IPN.PA | IPSEN | 11.68 | 10.06B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 100.48 | 9.30B | ||
| VIRP.PA | VIRBAC SA | 20.3 | 2.95B |
Related stock screener links
About SAN.PA
Company Profile
Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 84,587 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Company Info
SANOFI
46 Avenue de la Grande Armee
Paris ILE-DE-FRANCE FR
Employees: 82878
Phone: 33153774000
SANOFI / SAN.PA FAQ
Can you describe the business of SANOFI?
Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 84,587 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
What is the current price of SAN stock?
The current stock price of SAN.PA is 81.61 EUR. The price decreased by -0.74% in the last trading session.
Does SAN stock pay dividends?
SANOFI (SAN.PA) has a dividend yield of 4.77%. The yearly dividend amount is currently 3.79.
How is the ChartMill rating for SANOFI?
SAN.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the valuation of SANOFI (SAN.PA) based on its PE ratio?
The PE ratio for SANOFI (SAN.PA) is 10.74. This is based on the reported non-GAAP earnings per share of 7.6 and the current share price of 81.61 EUR.
What is the market capitalization of SAN stock?
SANOFI (SAN.PA) has a market capitalization of 198.23B EUR. This makes SAN.PA a Large Cap stock.
SAN.PA Technical Analysis
SAN.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to SAN.PA. While SAN.PA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
SAN.PA Financial Highlights
Over the last trailing twelve months SAN.PA reported a non-GAAP Earnings per Share(EPS) of 7.6. The EPS decreased by -5.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 20.35% | ||
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| Debt/Equity | 0.21 |
SAN.PA Forecast & Estimates
29 analysts have analysed SAN.PA and the average price target is 107.62 EUR. This implies a price increase of 31.87% is expected in the next year compared to the current price of 81.61.
For the next year, analysts expect an EPS growth of 3.02% and a revenue growth 0.64% for SAN.PA